Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756558 | SCV000884394 | pathogenic | not provided | 2018-01-12 | criteria provided, single submitter | clinical testing | The PMP22 c.307C>T; p.Gln103Ter variant was reported in a father and daughter with symptoms overlapping CMT1 and DSS (Pisciotta 2009). The c.307C>T variant creates a premature termination codon in exon 3 of 5 which is predicted to result in a truncated or absent protein product, and other PMP22 premature stop variants have been reported in patients diagnosed with CMT (Numakura 2002, Abe 2004, DiVincenzo 2014). This variant is absent from the general population databases (1000 Genomes Project, Exome Variant Server, Genome Aggregation Database). Based on the available information, the c.307C>T; p.Gln103Ter variant is classified as pathogenic. |
Inherited Neuropathy Consortium | RCV000790162 | SCV000929553 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |